Effects of Coenzyme Q10 in Early Parkinson Disease
University of California, San Diego
Indexed incrossrefpubmed
Abstract
Background
Parkinson disease (PD) is a degenerative neurological disorder for which no treatment has been shown to slow the progression.
Objective
To determine whether a range of dosages of coenzyme Q10 is safe and well tolerated and could slow the functional decline in PD.
Citation impact
975
total citations
- FWCI
- 20.59
- Percentile
- 100%
- References
- 51
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Coenzyme Q10
- Placebo
- Dose
- Medicine
- Parkinson's disease
- Internal medicine
- Rating scale
- Levodopa
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.